11.04.19 The Pharmacokinetic Differences Between Humans and Animals of KZR-616, a First-In-Class, Selective Immunoproteasome Inhibitor, In Two Clinical Formulations. American Association of Pharmaceutical Scientists PHARMSCI 360 2019 (AAPS 2019).
